MedPath

Seoul National University Hospital

Seoul National University Hospital logo
🇰🇷South Korea
Ownership
Private
Established
2003-01-01
Employees
501
Market Cap
-
Website
https://www.snubh.org

Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
First Posted Date
2011-07-19
Last Posted Date
2011-07-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
35
Registration Number
NCT01396668
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2011-07-19
Last Posted Date
2025-04-17
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
78
Registration Number
NCT01396655

Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
First Posted Date
2011-07-19
Last Posted Date
2011-07-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
70
Registration Number
NCT01396681
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Appetite Regulation by Human Chemosignals From Tears and Plasma

Not Applicable
Completed
Conditions
Obesity
Interventions
Biological: Sniffing trickled saline
Biological: Sniffing emotional tears
Biological: Sniffing fasting plasma
Biological: Sniffing postprandial plasma
First Posted Date
2011-07-08
Last Posted Date
2013-12-09
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
22
Registration Number
NCT01389869
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

MgSO4 Combined With Rocuronium Priming

Not Applicable
Conditions
Muscle Relaxation
Interventions
Drug: magnesium sulfate and priming
Drug: priming
First Posted Date
2011-07-08
Last Posted Date
2012-01-10
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
100
Registration Number
NCT01389791
Locations
🇰🇷

Seoul national university Bundang hospital, Seongnam, Kyoung-ki-do, Korea, Republic of

Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants

Phase 2
Completed
Conditions
Infant, Preterm
Interventions
Procedure: neurally adjusted ventilatory assist (NAVA) ventilator mode
First Posted Date
2011-07-08
Last Posted Date
2012-01-09
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
26
Registration Number
NCT01389882
Locations
🇰🇷

Seoul National University Children's Hospital, Seoul, Korea, Republic of

Distal Protection Device in ST-elevation Myocardial Infarction (STEMI)

Phase 4
Completed
Conditions
ST-segment Elevation Myocardial Infarction
Interventions
Device: distal protection and thrombus aspiration (The GuardWire Plus (Medtronic Inc.))
Procedure: c-PCI
First Posted Date
2011-06-28
Last Posted Date
2013-03-18
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
126
Registration Number
NCT01384019
Locations
🇰🇷

Seoul Natioinal University Bundang Hospital, Seongnam, Korea, Republic of

Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

Phase 2
Completed
Conditions
Hepatocellular Carcinoma
Interventions
Drug: m-TOR inhibitor free
First Posted Date
2011-06-16
Last Posted Date
2016-06-01
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
45
Registration Number
NCT01374750
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children

Phase 4
Conditions
Agitation
Interventions
First Posted Date
2011-06-16
Last Posted Date
2011-06-16
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
25
Registration Number
NCT01374737
Locations
🇰🇷

SNUH, Seoul, Korea, Republic of

The Effect of Dexmedetomidine on Postoperative Analgesia

Phase 4
Completed
Conditions
Colon Cancer, Rectal Cancer
Interventions
First Posted Date
2011-06-14
Last Posted Date
2012-03-08
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
95
Registration Number
NCT01373021
Locations
🇰🇷

Seoul national university hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath